Gall bladder/bile duct disease Acute pancreatitis and other pancreatic disorders have been reported, though the relationship to treatment is unclear Injection-site reactions Dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist Primary mechanism(s) of action Selectively binds and activates both GIP and GLP-1 receptors Example Tirzepatide (Mounjaro) Dosage Initial: 2.5 mg subcutaneous injection once weekly, titrated up to 5 mg weekly after 4 weeks If additional glycemic control is needed, dosage can be increased in 2.5 mg increments after at least 4 weeks on the current dosage
Perhaps most relevant to the resM formulation, one study found that incorporating 3% mulberry leaf extract into the diet for 8 weeks improved glycemic control, insulin sensitivity, and serum GLP-1 levels
Human and animal studies have shown GH-releasing activity with minimal influence on ACTH, prolactin, or cortisol when compared with several earlier growth hormone secretagogues
For best results, try pairing with Medik8 Advanced Day Ultimate Protect sunscreen
These ads usually promote compounded versions of the drugs, which are custom-mixed and not FDA-approved